Back to MNPR

Saturn V Capital Management LP → MNPR

Saturn V Capital Management LP MNPR Position History

Monopar Therapeutics Inc. • Healthcare

Quarters held
4
Latest value
$24.9M
Q3 2026
Peak value
$28.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$21.3M
Q1 2026$18.9M
Q2 2026$28.9M
Q3 2026$24.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$24.9M312.4K——
Q2 2026$28.9M312.0K——
Q1 2026$18.9M345.6K——
Q4 2025$21.3M325.7K——

Other funds holding MNPR

Other Saturn V Capital Management LP positions

AMLX

AMYLYX PHARMACEUTICALS INC

$130.1M
AAVXF

ABIVAX SA

$87.5M
AMLX

AMYLYX PHARMACEUTICALS INC

$83M
ALMS

ALUMIS INC

$82M
ALMS

ALUMIS INC

$70.5M
AAVXF

ABIVAX SA

$69.1M
AMLX

AMYLYX PHARMACEUTICALS INC

$60.5M
AAVXF

ABIVAX SA

$60.4M